| 摘要 |
PURPOSE: A pharmaceutical composition containing Bambusae Caulis in Liquamen is provided to suppress NO generation and remove free radical. CONSTITUTION: A pharmaceutical composition for treating or preventing oxidative injury caused by inflammatory disease or free radical contains pharmaceutically effective amount of Bambusae Caulis in Liquamen extract and pharmaceutically acceptable carrier. The pharmaceutical compositioin also contains pharmaceutically effective amount of 1,2-dihydroxybenzene or 1,4-dihydroxybenzene and pharmaceutically acceptable carrier. The 1,2-dihydroxybenzene or 1,4-dihydroxybenzene is isolated from Bambusae Caulis in Liquamen extract. The inflammatory disease is sinusitis, rhinitis, conjunctivitis, asthma, dermatitis, atopic dermatitis, inflammatory bowel disease, inflammatory collagen vascular diseases, glomerulonephritis, inflammatory skin diseases or sarcoidosis. The oxidative injury is atherosclerosis, cancer, emphysema, cirrhosis, or arthritis.
|
